Literature DB >> 1964060

Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs.

D Caussy1, S H Weiss, W A Blattner, J French, K P Cantor, H Ginzburg, R Altman, J J Goedert.   

Abstract

In a cross-sectional study of 926 subjects from 10 drug treatment programs conducted in 1984 in New Jersey, the seroprevalence of human immunodeficiency virus (HIV) was 35% overall; 30% in whites, 33% in hispanics, and 46% in blacks (p = 0.01 for comparison of blacks to non-blacks). Univariate analysis showed the seroprevalence of HIV was not associated with age or gender, but did correlate with frequency of cocaine or heroin injection (p trend less than 0.001); frequency of needle sharing (p trend = 0.007); and inversely with levels of education (p = 0.05). The prevalence of HIV was also inversely related to the distance of the treatment center from lower Manhattan; being highest for distances of less than 5 miles from lower Manhattan and lowest for distances of 80 miles, with intermediate rates for the intervening distances (p trend less than 0.001). In multivariate analyses, HIV seropositivity was consistently associated with the frequency of needle sharing (p = 0.02) and less than 12 years (high school level) of education (p = 0.02), but not with black race. However, blacks who shared needles less than once a month had a relative risk of 3.2 (95% CI 1.2, 7.7) while non-blacks who shared less than once a month had a relative risk of only 0.9 (95% CI 0.3, 2.4). The risk in non-blacks increased to more than twofold with more frequent needle sharing. When the analysis was stratified by gender and adjusted for needle sharing and geography, a significant twofold increased risk was observed for female (but not male) subjects who had two or more heterosexual partners compared with those who had one partner.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964060     DOI: 10.1089/aid.1990.6.1459

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence.

Authors:  S R Friedman; T Perlis; D C Des Jarlais
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

2.  Reduced probability of HIV infection among crack cocaine--using injection drug users.

Authors:  M Y Iguchi; D A Bux
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

3.  Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996.

Authors:  D C Des Jarlais; T Perlis; S R Friedman; S Deren; T Chapman; J L Sotheran; S Tortu; M Beardsley; D Paone; L V Torian; S T Beatrice; E DeBernardo; E Monterroso; M Marmor
Journal:  Am J Public Health       Date:  1998-12       Impact factor: 9.308

Review 4.  The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.

Authors:  S D Holmberg
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

5.  Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Holly Hagan; Courtney McKnight; David C Perlman; Samuel R Friedman
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

6.  Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1.

Authors:  João Dinis de Sousa; Carolina Alvarez; Anne-Mieke Vandamme; Viktor Müller
Journal:  Viruses       Date:  2012-10-03       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.